Gilead Sciences to Present at the Goldman Sachs 38th Annual Global Healthcare Conference on Thursday, June 15
June 01 2017 - 5:00PM
Business Wire
Webcast Available Through Gilead Corporate
Website
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Kevin
Young CBE, Gilead’s Chief Operating Officer, and Norbert W.
Bischofberger, PhD, Gilead’s Executive Vice President, R&D and
Chief Scientific Officer, will participate in a fireside chat at
the Goldman Sachs 38th Annual Global Healthcare Conference in
Ranchos Palos Verdes, CA on Thursday, June 15 at 10:00 a.m. Pacific
Time.
The audio portion of the fireside chat will be accessible live
through the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior
to the start of the presentation to ensure adequate time for any
software download that may be required to listen to the webcast.
The replay will be available for 14 days following the
presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers,
develops and commercializes innovative therapeutics in areas of
unmet medical need. The company’s mission is to advance the care of
patients suffering from life-threatening diseases. Gilead has
operations in more than 30 countries worldwide, with headquarters
in Foster City, California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170601006210/en/
Gilead Sciences, Inc.Sung Lee, 650-524-7792Investor
Relations
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Sep 2023 to Sep 2024